Gilder Gagnon Howe & CO LLC Synlogic, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.27 - $3.0 $376,613 - $497,727	-165,909 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.45 - $4.1 $2.82 Million - $4.72 Million	-1,152,016 Reduced 87.41%	165,909 $506,000
Q2 2021 Aug 16, 2021	SELL	$3.0 - $4.39 $513,552 - $751,497	-171,184 Reduced 11.5%	1,317,925 $5.13 Million
Q1 2021 May 17, 2021	BUY	$2.2 - $5.05 $3.28 Million - $7.52 Million	1,489,109 New	1,489,109 $5.33 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $99.7M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.